ClinVar Miner

Submissions for variant NM_033380.3(COL4A5):c.1147G>C (p.Gly383Arg)

dbSNP: rs1569492161
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Molecular Medicine Center, Medical University of Sofia RCV000785979 SCV000920797 pathogenic Alport syndrome 2019-06-11 criteria provided, single submitter clinical testing Identified in all affected individuals, both male and female, in a large pedigree.
Invitae RCV001869174 SCV002247687 likely pathogenic not provided 2021-01-11 criteria provided, single submitter clinical testing Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL4A5 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the triple helix domain of COL4A5. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL4A5, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 23720012, 27627812) compared to the general population (ExAC). This variant has been observed in individual(s) with clinical features of Alport syndrome (Invitae). ClinVar contains an entry for this variant (Variation ID: 635111). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 383 of the COL4A5 protein (p.Gly383Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.